Clinical benefit of continuing pembrolizumab treatment beyond progression in patients with metastatic urothelial carcinoma
暂无分享,去创建一个
S. Egawa | Masatoshi Tanaka | Shunsuke Tsuzuki | M. Honda | J. Miki | T. Yanagisawa | S. Kimura | W. Fukuokaya | H. Onuma | T. Kimura | F. Urabe | Yuya Iwamoto | Yuki Enei | H. Abe | Yuri Oyama | Yuhei Koike